Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Calibrating Observational Health Record Data Against a Randomized Trial.
Merola D, Campbell U, Lenis D, Schneeweiss S, Wang S, Madsen A, Carrigan G, Chia V, Ovbiosa OE, Pinheiro S, Pace N, Bruno A, Stewart M, Khosla S, Zhang Y, Rimawi M, Hendricks-Sturrup R, Huang J, Taylor A, Jiao X, Becnel L, McRoy L, Eckert J, Rodriguez C, Lunacsek O, Harvey R, Greshock J, Sarsour K, Belli A, Wang CK, Fernandes L, Chen J, San Francisco B, Sangli C, Natanzon Y, Chan KA, Dhopeshwarkar N, Shapiro M, Wasserman A, Quinn J, Rees M, Robinson T, Taylor B, Rider JR. Merola D, et al. Among authors: taylor b, taylor a. JAMA Netw Open. 2024 Sep 3;7(9):e2436535. doi: 10.1001/jamanetworkopen.2024.36535. JAMA Netw Open. 2024. PMID: 39348118 Free PMC article.
The Aetion Coalition to Advance Real-World Evidence through Randomized Controlled Trial Emulation Initiative: Oncology.
Merola D, Campbell U, Gautam N, Rubens A, Schneeweiss S, Wang SV, Carrigan G, Chia V, Ovbiosa OE, Pinheiro S, Bruno A, Jiao X, Stewart M, Hendricks-Sturrup R, Rodriguez-Watson C, Khosla S, Zhang Y, Rimawi M, Huang J, Taylor A, Becnel L, McRoy L, Eckert J, Taylor B. Merola D, et al. Among authors: taylor b, taylor a. Clin Pharmacol Ther. 2023 Jun;113(6):1217-1222. doi: 10.1002/cpt.2800. Epub 2022 Dec 7. Clin Pharmacol Ther. 2023. PMID: 36408668 Review.
Real-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United States.
Kalinsky K, Spring L, Yam C, Bhave MA, Ntalla I, Lai C, Sjekloca N, Stwalley B, Stokes M, Taylor A, Nanda R. Kalinsky K, et al. Among authors: taylor a. Breast Cancer Res Treat. 2024 Nov;208(1):203-214. doi: 10.1007/s10549-024-07412-9. Epub 2024 Jun 21. Breast Cancer Res Treat. 2024. PMID: 38904892 Free PMC article.
Neoadjuvant atezolizumab + chemotherapy for resectable NSCLC: 3-year clinical update of phase II clinical trial results and translational findings.
Henick BS, Koch PD, Gainor JF, Awad MM, Chiuzan C, Izard S, Georgis Y, Mallick S, Garofano RF, Wong CV, Saqi A, Grindheim J, Schulze K, Sonett JR, Rizvi NA, Izar B, Taylor AM, Shu CA. Henick BS, et al. Among authors: taylor am. J Immunother Cancer. 2024 Dec 25;12(12):e009301. doi: 10.1136/jitc-2024-009301. J Immunother Cancer. 2024. PMID: 39721753 Free article. Clinical Trial.
Integrating vocational supports into a transition clinic: A pilot program.
Hale EW, Taylor A, Elton M, Honsbruch M, Rosenberg CR, Sanders JS. Hale EW, et al. Among authors: taylor a. Health Care Transit. 2024 Feb 27;2:100048. doi: 10.1016/j.hctj.2024.100048. eCollection 2024. Health Care Transit. 2024. PMID: 39712592 Free PMC article.
DNA methylation-based predictors of metabolic traits in Scottish and Singaporean cohorts.
Smith HM, Ng HK, Moodie JE, Gadd DA, McCartney DL, Bernabeu E, Campbell A, Redmond P, Taylor A, Page D, Corley J, Harris SE, Tay D, Deary IJ, Evans KL, Robinson MR, Chambers JC, Loh M, Cox SR, Marioni RE, Hillary RF. Smith HM, et al. Among authors: taylor a. Am J Hum Genet. 2024 Dec 13:S0002-9297(24)00421-X. doi: 10.1016/j.ajhg.2024.11.012. Online ahead of print. Am J Hum Genet. 2024. PMID: 39706196 Free article.
Eight-fold increased COVID-19 mortality in autosomal dominant tubulointerstitial kidney disease due to MUC1 mutations: an observational study.
Kidd KO, Williams AH, Taylor A, Martin L, Robins V, Sayer JA, Olinger E, Mabillard HR, Papagregoriou G, Deltas C, Stavrou C, Conlon PJ, Hogan RE, Elhassan EAE, Springer D, Zima T, Izzi C, Vrbacká A, Piherová L, Pohludka M, Radina M, Vylet'al P, Hodanova K, Zivna M, Kmoch S, Bleyer AJ Sr. Kidd KO, et al. Among authors: taylor a. BMC Nephrol. 2024 Dec 18;25(1):449. doi: 10.1186/s12882-024-03896-1. BMC Nephrol. 2024. PMID: 39696072 Free PMC article.
10,407 results
You have reached the last available page of results. Please see the User Guide for more information.